Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN1881304 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-V-Erb-B2 erythroblastic Leukemia Viral Oncogene Homolog 2, Neuro/glioblastoma Derived Oncogene Homolog (Avian) (ERBB2) (pTyr1112) antibody
- Antibody type
- Polyclonal
- Antigen
- This ErbB2 Antibody is generated from rabbits immunized with a KLH conjugated synthetic phosphopeptide corresponding to amino acid residues surrounding Y1112 of human ErbB2.
- Description
- This antibody is purified through a protein A column, followed by peptide affinity purification. Peptide Affinity Purified Rabbit Polyclonal Antibody (Pab)
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- pTyr1112
- Antibody clone number
- RB40063
- Vial size
- 400 μL
- Concentration
- 0.5 mg/mL
Submitted references Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2.
Lung cancer: intragenic ERBB2 kinase mutations in tumours.
Is the circulating urokinase plasminogen activator upregulated by the circulating p105 fraction of the HER-2/neu proto-oncogene in patients with cervical cancer?
Clinical relevance of HER-2/neu expression in germ-cell testicular tumors.
Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells.
Wang SC, Lien HC, Xia W, Chen IF, Lo HW, Wang Z, Ali-Seyed M, Lee DF, Bartholomeusz G, Ou-Yang F, Giri DK, Hung MC
Cancer cell 2004 Sep;6(3):251-61
Cancer cell 2004 Sep;6(3):251-61
Lung cancer: intragenic ERBB2 kinase mutations in tumours.
Stephens P, Hunter C, Bignell G, Edkins S, Davies H, Teague J, Stevens C, O'Meara S, Smith R, Parker A, Barthorpe A, Blow M, Brackenbury L, Butler A, Clarke O, Cole J, Dicks E, Dike A, Drozd A, Edwards K, Forbes S, Foster R, Gray K, Greenman C, Halliday K, Hills K, Kosmidou V, Lugg R, Menzies A, Perry J, Petty R, Raine K, Ratford L, Shepherd R, Small A, Stephens Y, Tofts C, Varian J, West S, Widaa S, Yates A, Brasseur F, Cooper CS, Flanagan AM, Knowles M, Leung SY, Louis DN, Looijenga LH, Malkowicz B, Pierotti MA, Teh B, Chenevix-Trench G, Weber BL, Yuen ST, Harris G, Goldstraw P, Nicholson AG, Futreal PA, Wooster R, Stratton MR
Nature 2004 Sep 30;431(7008):525-6
Nature 2004 Sep 30;431(7008):525-6
Is the circulating urokinase plasminogen activator upregulated by the circulating p105 fraction of the HER-2/neu proto-oncogene in patients with cervical cancer?
Contreras DN, Cobos E, Lox C
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2004 Jul;10(3):271-6
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2004 Jul;10(3):271-6
Clinical relevance of HER-2/neu expression in germ-cell testicular tumors.
Mándoky L, Géczi L, Bodrogi I, Tóth J, Csuka O, Kásler M, Bak M
Anticancer research 2004 Jul-Aug;24(4):2219-24
Anticancer research 2004 Jul-Aug;24(4):2219-24
Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells.
Menendez JA, Vellon L, Mehmi I, Oza BP, Ropero S, Colomer R, Lupu R
Proceedings of the National Academy of Sciences of the United States of America 2004 Jul 20;101(29):10715-20
Proceedings of the National Academy of Sciences of the United States of America 2004 Jul 20;101(29):10715-20
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- Dot blot analysis of Phospho-ERBB2-Y1112 Phospho-specific Pab (ABIN1881304) on nitrocellulose membrane. 50 ng of Phospho-peptide or Non Phospho-peptide per dot were adsorbed. Antibody working concentrations are 0.6 μg per mL.
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- Dot blot analysis of Phospho-ERBB2-Y1112 Phospho-specific Pab (ABIN1881304) on nitrocellulose membrane. 50 ng of Phospho-peptide or Non Phospho-peptide per dot were adsorbed. Antibody working concentrations are 0.6 μg per mL.